Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADAR: Switching to Once-Daily Darunavir/Ritonavir in Suppressed HIV-1
NCT00849160Phase 3Completed
- Sponsor
- Centre de Recherches et d'Études sur la Pathologie Tropicale et le Sida
- Start
- May 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Centre de Recherches et d'Études sur la Pathologie Tropicale et le Sida. Started May 2009; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00849160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00849160.